Similar articles

• Rituximab in combination with interferon-alpha in relapsed and refractory diffuse large B-cell non-Hodgkin's lymphoma.

  Bertè R, Vallisa D, Civardi G, Moroni CF, Lazzaro A, Cavanna L. Bertè R, et al. Acta Haematol. 2001;106(3):141-2. doi: 10.1159/000046607. Acta Haematol. 2001. PMID: 11713384 No abstract available.
• [Treatment of primary mediastinal large B-cell lymphomas].

  Schneider T, Tóth E, Molnár Z, Várady E, Deák B, Horváth A, Horváth GI, Eid H, Schneider K, Lovey J, Keresztes S, Esik O, Lengyel Z, Rosta A. Schneider T, et al. Orv Hetil. 2004 Dec 12;145(50):2531-7. Orv Hetil. 2004. PMID: 15662753 Hungarian.
• Bilateral hard palate masses.

  Schaberg SJ, Daniels CA, Loomer L, Addante RR. Schaberg SJ, et al. J Oral Maxillofac Surg. 1993 Nov;51(11):1262-7. doi: 10.1016/s0278-2391(10)80299-x. J Oral Maxillofac Surg. 1993. PMID: 7693900 No abstract available.
• [Non-Hodgkin's lymphomas: recent achievements and therapeutic perspectives].

  Bron D, Vandenheule B, Stryckmans P. Bron D, et al. Rev Med Brux. 1985 Sep;6(7):491-5. Rev Med Brux. 1985. PMID: 2417298 Review. French. No abstract available.
• [Chylothorax resulting from malignant non Hodgkin's lymphoma].

  Ohyama S, Bando K, Hasegawa Y, Taniguti M, Shirayma H. Ohyama S, et al. Nihon Kokyuki Gakkai Zasshi. 1998 May;36(5):473-7. Nihon Kokyuki Gakkai Zasshi. 1998. PMID: 9742867 Review. Japanese.